Allogene Therapeutics (ALLO) Other Gross PP&E Adjustments (2019 - 2025)
Allogene Therapeutics (ALLO) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with $79.5 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments fell 2.44% to $79.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $79.5 million through Dec 2025, down 2.44% year-over-year, with the annual reading at $79.5 million for FY2025, 2.44% down from the prior year.
- Other Gross PP&E Adjustments hit $79.5 million in Q4 2025 for Allogene Therapeutics, down from $104.5 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $146.2 million in Q3 2024 to a low of $40.4 million in Q4 2022.
- Historically, Other Gross PP&E Adjustments has averaged $87.7 million across 5 years, with a median of $83.8 million in 2024.
- Biggest five-year swings in Other Gross PP&E Adjustments: crashed 45.13% in 2022 and later skyrocketed 103.59% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at $73.6 million in 2021, then plummeted by 45.13% to $40.4 million in 2022, then surged by 52.25% to $61.5 million in 2023, then skyrocketed by 32.53% to $81.5 million in 2024, then fell by 2.44% to $79.5 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for ALLO at $79.5 million in Q4 2025, $104.5 million in Q3 2025, and $103.9 million in Q2 2025.